
PennCVI
@penncvi
The University of Pennsylvania CardioVascular Institute (CVI)
ID: 1312076345594335232
02-10-2020 17:06:27
460 Tweet
549 Followers
52 Following















CHOP & Penn Medicine have delivered the first-ever personalized gene editing therapy for a patient with CPS1 deficiency, marking a major milestone in the application of CRISPR-based treatments. Learn more about KJ & the future of personalized medicine: ms.spr.ly/6015SZLAx.




